Search results
Results from the WOW.Com Content Network
Long-term use of benzodiazepines can induce perceptual disturbances and depersonalization in some people, even in those taking a stable daily dosage, and it can also become a protracted withdrawal feature of the benzodiazepine withdrawal syndrome. [54] In addition, chronic use of benzodiazepines is a risk factor for blepharospasm. [55]
Clonazepam, sold under the brand name Klonopin among others, is a benzodiazepine medication used to prevent and treat anxiety disorders, seizures, bipolar mania, agitation associated with psychosis, obsessive–compulsive disorder (OCD), and akathisia. [11]
There’s a difference between being totally over your day and sundowning. In addition to the symptoms listed above, sundowning can include verbal or even physical outbursts, Elhelou says.
According to the Government of Victoria's (Australia) Department of Health, long-term use can cause "impaired thinking or memory loss, anxiety and depression, irritability, paranoia, aggression, etc." [9] A minority of people have paradoxical reactions after taking benzodiazepines such as worsened agitation or panic.
Here’s how it can help keep your body healthy and your brain sharp. ... (that’s a state in which you may have episodes of confusion). Many of these conditions can be temporary, if you get the ...
Failure to treat benzodiazepine dependence in the elderly can cause serious medical complications. [14] The elderly have less cognitive reserve and are more sensitive to the short (e.g., in between dose withdrawal) and protracted withdrawal effects of benzodiazepines, as well as the side-effects both from short-term and long-term use.
But when older people have serious difficulties or feel isolated, the outcomes can be devastating: A new AARP survey finds that one in three women over age 60 report feeling sometimes or often ...
The consensus is to reduce dosage gradually over several weeks, e.g. 4 or more weeks for diazepam doses over 30 mg/day, [1] with the rate determined by the person's ability to tolerate symptoms. [120] The recommended reduction rates range from 50% of the initial dose every week or so, [121] to 10–25% of the daily dose every 2 weeks. [120]